The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5,710.00
Bid: 5,700.00
Ask: 5,705.00
Change: 40.00 (0.71%)
Spread: 5.00 (0.088%)
Open: 5,615.00
High: 5,715.00
Low: 5,605.00
Prev. Close: 5,670.00
DCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

11 Feb 2016 07:00

RNS Number : 7132O
DCC PLC
11 February 2016
 

 

 

11 February 2016

 

DCC plc

 

Interim Management Statement

 

DCC Reports Very Strong Growth in Third Quarter Operating Profit

 

DCC plc, the international sales, marketing, distribution and business support services group, is issuing this Interim Management Statement for the third quarter ended 31 December 2015.

 

Third quarter ended 31 December 2015

Group operating profit in the third quarter ended 31 December 2015 was very significantly ahead of the prior year. There was excellent growth in operating profit in each of DCC Energy, DCC Healthcare and DCC Environmental with more difficult trading conditions in DCC Technology.

 

Operating profit in DCC Energy was very significantly ahead of the prior year, despite the milder winter weather conditions. The two large acquisitions completed earlier in the financial year, Esso Retail France and Butagaz, performed in line with, or modestly ahead of, expectations. Whilst overall heating-related volumes were held back by the mild temperatures, a good margin and cost performance was achieved.

 

Operating profit in DCC Technology was behind the prior year, as the business continued to be impacted by reduced demand for tablet, smartphone and gaming products.

 

DCC Healthcare traded well ahead of the prior year, benefiting from a very strong performance from DCC Health & Beauty Solutions and a continued improvement in the sales mix and good cost control in DCC Vital.

 

Operating profit in DCC Environmental was strongly ahead of the prior year.

 

Year to 31 March 2016

DCC continues to expect that both operating profit and adjusted earnings per share will be very significantly ahead of the prior year and in line with current market consensus.

 

Development Activity

The year to 31 March 2016 has been a milestone year for development in DCC with the completion earlier in the financial year of DCC's two largest acquisitions to date, Butagaz and Esso Retail France. The cash outflow on acquisitions completed in the nine months to 31 December 2015 (which includes the previously committed acquisitions of Butagaz and Esso Retail France), inclusive of a net movement in deferred and contingent acquisition consideration, was £385 million. Total committed acquisition expenditure in the nine months to 31 December 2015 was £39 million.

 

DCC remains ambitious to continue the growth and development of its business in existing and new geographies and retains a strong, well-funded and liquid balance sheet.

 

Final Results

DCC expects to announce its results for the year to 31 March 2016 on 17 May 2016.

 

 

For reference:

Tommy Breen, Chief Executive

Fergal O'Dwyer, Chief Financial Officer

Kevin Lucey, Head of Group Finance & Investor Relations

 

Telephone: +353 1 2799400

Email: investorrelations@dcc.ie

Web: www.dcc.ie

 

 

 

 

 

About DCC plc

DCC plc is an international sales, marketing, distribution and business support services group headquartered in Dublin with operations in Britain, Continental Europe and Ireland. DCC has four divisions - DCC Energy, DCC Technology, DCC Healthcare and DCC Environmental. In its last financial year ended 31 March 2015, DCC generated revenue of £10.6 billion and operating profit from continuing activities of £222 million and currently employs approximately 11,000 people in 14 countries. DCC's shares are listed on the London Stock Exchange and are included in the FTSE 100 Index.  

 

Forward-looking statements

This announcement contains some forward-looking statements that represent DCC's expectations for its business, based on current expectations about future events, which by their nature involve risk and uncertainty. DCC believes that its expectations and assumptions with respect to these forward-looking statements are reasonable, however because they involve risk and uncertainty as to future circumstances, which are in many cases beyond DCC's control, actual results or performance may differ materially from those expressed in or implied by such forward-looking statements.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDBLFFQLFFBBL
Date   Source Headline
23rd Dec 201912:44 pmRNSHolding in Company TR-1
5th Dec 20195:44 pmRNSHolding in Company - TR1
29th Nov 20191:39 pmRNSTotal Voting Rights
27th Nov 20199:18 amRNSDirector Declaration
18th Nov 20196:14 pmRNSDirector/PDMR Shareholding
12th Nov 20197:00 amRNSResults for the six months ended 30 September 2019
12th Nov 20197:00 amRNSDCC Healthcare acquires Ion Laboratories
7th Nov 201911:30 amRNSHolding in Company TR-1
23rd Oct 20192:25 pmRNSHolding in Company TR-1
21st Oct 20195:01 pmRNSHolding in Company TR-1
18th Oct 20194:46 pmRNSHolding in Company TR-1
17th Oct 20199:43 amRNSHolding in Company TR-1
25th Sep 20195:39 pmRNSHolding in Company TR-1
4th Sep 20199:57 amRNSHolding in Company TR-1
9th Aug 201910:42 amRNSHolding in Company TR-1
7th Aug 20199:23 amRNSHolding in Company TR-1
31st Jul 20192:58 pmRNSTotal Voting Rights
16th Jul 20196:14 pmRNSDirector/PDMR Shareholding
12th Jul 20193:06 pmRNSResult of AGM
12th Jul 20197:00 amRNSInterim Management Statement
5th Jul 20199:06 amRNSHolding in Company TR-1
19th Jun 20199:22 amRNSHolding in Company TR-1
13th Jun 201911:37 amRNS2019 Annual Report, Notice of AGM and Proxy Form
31st May 20199:47 amRNSTotal Voting Rights
28th May 20197:00 amRNSHolding in Company TR-1
23rd May 20196:25 pmRNSDirector/PDMR Shareholding
22nd May 20199:43 amRNSHolding in Company TR-1
16th May 20199:03 amRNSHolding in Company TR-1
14th May 20197:01 amRNSDCC Development Update
14th May 20197:00 amRNSResults for the year ended 31 March 2019
13th May 201910:14 amRNSBoard Change
28th Mar 20198:47 amRNSDirector Declaration
28th Feb 20199:00 amRNSTotal Voting Rights
5th Feb 20197:00 amRNSInterim Management Statement
1st Feb 20194:25 pmRNSHolding in Company TR-1
25th Jan 20193:12 pmRNSHolding in Company TR-1
22nd Jan 20192:27 pmRNSHolding in Company TR-1
10th Jan 201912:58 pmRNSHolding in Company TR-1
2nd Jan 20193:07 pmRNSHolding in Company TR-1
14th Dec 201811:50 amRNSHolding in Company TR-1
12th Dec 20189:08 amRNSHolding in Company TR-1
30th Nov 20183:03 pmRNSTotal Voting Rights
29th Nov 20184:50 pmRNSHolding in Company TR-1
19th Nov 20186:01 pmRNSHolding in Company TR-1
19th Nov 20185:59 pmRNSDirector/PDMR Shareholding
19th Nov 20182:27 pmRNSDirector/PDMR Shareholding
13th Nov 20187:00 amRNSResults for the six months ended 30 September 2018
6th Nov 20185:45 pmRNSHolding in Company TR-1
31st Oct 20183:26 pmRNSTotal Voting Rights
30th Oct 20189:51 amRNSBoard Resignation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.